Forest Laboratories Holdings Ltd. acquires Saphris

On December 2, 2013, Forest Laboratories Holdings Ltd. acquired Saphris, a medical products company in United States, from Merck Sharp & Dohme B.V.

Deal at a glance

AnnouncedDecember 2, 2013 TypeDivestiture TargetSaphris Buyer Forest Laboratories Holdings Ltd. Seller Merck Sharp & Dohme B.V. SectorMedical Products LocationUnited States ValueMembers only

Target company

Saphris

United States

Medical Productssector

-founded

Activestatus

View the company profile →

Buyer

Forest Laboratories Holdings Ltd.

Company · 1 deal on record

1st transaction in medical products
1st transaction in United States

1deals, all time

1in this sector

2013latest

Seller

Merck Sharp & Dohme B.V.

Company · 2 deals on record

2investments

1in this sector

1exits

Members only

Contact details at the buyers and sellers

The full deal history of every party

Co-investors and the other advisors on this deal

Deal value and revenue or EBITDA multiples

Related deals

Seraplex, Inc.Same sector and country · Oct 2026

Aloe Care Health, Inc.Same sector and country · Apr 2026

Hologic, Inc.Same sector and country · Apr 2026

Questions about this deal

Who acquired Saphris?Forest Laboratories Holdings Ltd. acquired Saphris on December 2, 2013.

Who sold Saphris?Merck Sharp & Dohme B.V. was the seller.

What type of deal was it?It was a divestiture in the medical products sector in 2013.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.

Try it free

Data updated daily on AcquityData (Acquity Data).